Toray Of Japan, University Develop Insulin Nasal Spray For Diabetes
This article was originally published in PharmAsia News
Japan's Toray Industries and a university disclosed they have developed an insulin for diabetics that can be administered through a nasal spray. Toray and Hoshi University said their method combines a peptide with insulin to form a liquid that can be delivered in spray form. The method, if proven successful, would substitute for diabetic reliance on regular insulin injections. Testing of the method in mice, according to researchers, showed that 50 percent of the insulin administered in that manner enters the blood to help lower blood sugar levels. The team plans to begin clinical trials to prove the method is efficacious and safe in humans. (Click here for more - a subscription may be required
You may also be interested in...
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.